Genetic Technologies has received its clinical laboratory permit from the New York State Department of Health (DoH). Genetic Technologies received a positive Laboratory Evaluation Report with "No significant deficiencies" following an ...
Tags: Health, Medicine, Genetic Technologies
The US Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist line of ready-to-administer prefilled generic injectables. The third BD Simplist product to be introduced includes Ondansetron ...
Therapeutic antibodies developer AnaptysBio has expanded its proprietary immunotherapy antibody portfolio to add multiple new combination therapies. The company developed a proprietary anti-PD-1 antibody, called ANB011, with key ...
Tags: AnaptysBio, Antibody Portfolio
The California State Assembly has passed a bill that restricts generic versions of medicines called biosimilars, upon their launch in the US. Biosimilars are medicines whose active drug substance is derived from living cells. They have ...
Tags: Biosimilar Drugs Bill, Medicine
Celator Pharmaceuticals, a pharmaceutical company developing therapies to treat cancer, has received US patent titled, ‘Lipid Carrier Compositions with Enhanced Blood Stability’ from the US Patent and Trademark Office on 27 ...
Cell Signaling Technology has presented a specific HER3 rabbit monoclonal antibody (mAb) for researchers studying HER2-mediated breast, lung and ovarian tumors. The company has introduced this product with the recent need for HER3 in HER2 ...
Bayer HealthCare and Onyx Pharmaceuticals have announced FDA priority review designation for Nexavar (sorafenib) supplemental new drug application for the treatment of radioactive iodine-refractory differentiated thyroid cancer. Nexavar ...
Tags: New Drug Application, FDA
LifeAgain Insurance Solutions, a wholly-owned subsidiary of Cardium Therapeutics, has signed a commercialisation agreement with insurance broker AgencyONE to support the development and marketing of new survivable risk life insurance ...
GeneDx, a US-based genetic testing laboratory, has introduced a new suite of genetic tests for inherited cancer, including breast and colon cancer. To be marketed under OncoGeneDx brand, the new suite of genetic tests include a 26-gene ...
Tags: Genetic Tests, Inherited Cancer
Traditional Chinese medicine may be the latest sector to benefit from cosmic farming as 150 grams of space-exposed ginseng seeds were delivered to a State lab on Friday. "We hope the space ginseng will be bigger, more resistant to disease ...
Ceptaris Therapeutics has obtained FDA marketing approval for Valchlor (mechlorethamine) gel to topically treat stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma (CTCL) patients who were exposed to skin-directed therapy ...
Tags: Valchlor Gel, Ceptaris
US-based Provision Center for Proton Therapy has selected RaySearch Laboratories' RayStation treatment planning system as part of a partnership signed earlier in 2013 by both firms. Provision Center for Proton Therapy president Mary Lou ...
Eight out of ten women in the UK agree that bright, colorful packaging tends to make products attractive to children aged under 18, according to new figures published by Cancer Research UK. The YouGov survey conducted for more than 2000 ...
Tags: Colorful Tobacco, Packaging
Abbott has completed its acquisition of Idev Technologies, a privately held firm that manufactures next-generation medical devices for use by interventional radiologists, vascular surgeons and cardiologists, for $310m. Abbott believes ...
Tags: Abbott, Idev Technologies
Biopharmaceutical company Galena Biopharma has announced patent notification from the European Patent Office for pharmaceutical use of NeuVax (nelipepimut-S) as a vaccine for the prevention of relapse in breast cancer patients. The patent ...
Tags: Galena Biopharma, Neuvax